AstraZeneca Collaboration With Medical Research Council May Mean New Life For 22 Compounds
This article was originally published in The Pink Sheet Daily
U.K.-based academic research teams will be able to apply to work with the AstraZeneca compounds free of charge and receive grant funding from MRC under the collaboration.
You may also be interested in...
Biotech licenses drug composition patents from University of Alaska Fairbanks for study in several disease states. Gilead seeks long-acting HIV therapy or prevention with broadly neutralizing antibodies discovered by Rockefeller U.
Britain moves ahead with a drug-repurposing research program that brings together big pharma and academic researchers in novel collaborations.
Disparate events including Hurricane Sandy, extended-release generics, drug compounding and biopharma deal-making each highlighted just how important a challenge quality has become in the industry.